Key Trends Shaping the Future Immunohematology Market From 2025-2034: Revolutionizing Blood Transfusion Testing With Innovative Solutions

Which drivers are expected to have the greatest impact on the over the immunohematology market's growth?
Anticipated growth in the immunohematology market is primarily attributable to the increasing prevalence of hematological disorders. These disorders represent a diverse set of conditions affecting various portions of the blood including red and white blood cells, platelets, and plasma. Blood transfusions' safety and efficacy are largely dependent on immunohematology, which is crucial in preventing adverse reactions to transfusions brought on by blood type incompatibilities or presence of antibodies in recipient blood. Immunohematology methods additionally serve diagnostic and therapeutic purposes for diseases with potential impacts on the hematological system. As an illustration, Cancer Research UK, a UK-based research entity, predicts that new leukemia occurrences emanating from hematologic disorders in the UK will ascend, from an estimated 12,400 cases during 2023-2025 to approximately 14,500 cases during 2038-2040. Consequently, the escalating prevalence of hematological disorders is fuelling the expansion of the immunohematology market.

Get Your Immunohematology Market Report Here:
https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

What is the future CAGR of the immunohematology market, and how will it impact industry expansion?
The size of the immunohematology market has experienced stable growth in recent years, with an expected increase from $2.46 billion in 2024 to $2.57 billion in 2025, representing a compound annual growth rate (CAGR) of 4.6%. Factors contributing to this growth in the historical period include improvements in the science of blood transfusion, the incidence of blood disorders, the development of blood banks, government efforts to ensure blood safety, an increase in surgical procedures, and heightened awareness about the risks associated with transfusion.

Expectations are set high for the immunohematology market, as it is predicted to witness substantial growth in the coming years. By 2029, the market size is estimated to reach "$3.24 billion, projected at a compound annual growth rate (CAGR) of 5.9%. The anticipated growth during the forecast period is driven by the increasing need for point-of-care testing, the introduction of new blood products, healthcare infrastructure development, blood compatibility genetic testing, and regulatory backing for blood safety. The forthcoming period will see significant trends such as automation, high-throughput systems, molecular techniques for blood typing, techniques for antibody detection, patient blood management schemes, incorporation of AI in analysis, and the integration of telemedicine.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

What are the most significant trends transforming the immunohematology market today?
Leading companies in the immunohematology market are paying attention to the development of ground-breaking diagnostic methods such as soluble recombinant proteins, which are created to counteract the interruption from the cancer therapy daratumumab. Soluble recombinant protein is a protein that is still accurately folded and active within a host cell or solution due to its manufacture through recombinant DNA technology, making it advantageous in both research and medical applications. For example, Grifols, S.A., a pharmaceutical company based in Spain, unveiled the Grifols sCD38 solution in November of 2023. This marks the first-ever soluble recombinant protein, Grifols' sCD38, engineered to counteract the disruption from the cancer treatment daratumumab during crucial blood transfusion compatibility tests. It's specifically designed for multiple myeloma patients, this seminal solution prevents daratumumab from binding with CD38 proteins on red blood cells, ensuring accurate pre-transfusion test results. Grifols sCD38 refines blood transfusion procedures and decreases wait times for potentially life-saving transfusions by streamlining the process of screening, identification, and crossmatching.

Which key market segments comprise the immunohematology market and drive its revenue growth?
The immunohematology market covered in this report is segmented -

1) By Product: Analyzers And Systems, Reagents
2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)
3) By Disease: Blood-Related Diseases, HIV, Hepatitis
4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology
5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Subsegments:
1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems
2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10295

What regions are at the forefront of immunohematology market expansion?
North America was the largest region in the immunohematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the leading players fueling growth in the immunohematology market?
Major companies operating in the immunohematology market include Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

What Is Covered In The Immunohematology Global Market Report?

• Market Size Forecast: Examine the immunohematology market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the immunohematology market for a structured understanding.
• Key Players Overview: Analyze major players in the immunohematology market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the immunohematology market.
• Segment Contributions: Evaluate how different segments drive overall growth in the immunohematology market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the immunohematology market.
• Industry Challenges: Identify potential risks and obstacles affecting the immunohematology market.
• Competitive Landscape: Review strategic developments in the immunohematology market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.